Debt > Equity? | Ep. 631
Using Debt as a Strategic Financing Tool
Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update. For the week XBI was DOWN -8% and remains red at -13% for the year. In today’s newsletter, we break down the shifting venture landscape - slower fundraising, lower valuations, and the rise of venture debt. Biotech …
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.